|
1
|
Berner K, Johannesen TB, Berner A,
Haugland HK, Bjerkehagen B, Bøhler PJ and Bruland ØS: Time-trends
on incidence and survival in a nationwide and unselected cohort of
patients with skeletal osteosarcoma. Acta Oncol. 54:25–33.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lee L, Fei L, Pope J and Wagner LM: Early
lymphocyte recovery and outcome in osteosarcoma. J Pediatr Hematol
Oncol. 39:179–183. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
O'Brien K and Chaman CL: An investigation
into the nutritional status and interventions taken in paediatric
and adolescent patients undergoing map chemotherapy for
osteosarcoma. Clin Nutr. 3(271)2018.
|
|
4
|
Bellini G, Di Pinto D, Tortora C, Manzo I,
Punzo F, Casale F and Rossi F: The role of mifamurtide in
chemotherapy-induced osteoporosis of children with osteosarcoma.
Curr Cancer Drug Targets. 17:650–656. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z and Wang J: lncRNA HOXA11-AS promotes
proliferation and invasion of gastric cancer by scaffolding the
chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res.
76:6299–6310. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lee S, Kopp F, Chang TC, Sataluri A, Chen
B, Sivakumar S, Yu H, Xie Y and Mendell JT: Noncoding RNA NORAD
regulates genomic stability by sequestering PUMILIO proteins. Cell.
164:69–80. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan
Q, Cheng D, Chen H, Deng X, Peng C and Shen B: Long noncoding RNA
NORAD, a novel competing endogenous RNA, enhances the
hypoxia-induced epithelial-mesenchymal transition to promote
metastasis in pancreatic cancer. Mol Cancer. 16(169)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Du Y, Liu XH, Zhu HC, Wang L, Ning JZ and
Xiao CC: miR-543 promotes proliferation and Epithelial-Mesenchymal
transition in prostate cancer via targeting RKIP. Cell Physiol
Biochem. 41:1135–1146. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mesci A, Huang X, Taeb S, Jahangiri S, Kim
Y, Fokas E, Bruce J, Leong HS and Liu SK: Targeting of CCBE1 by
miR-330-3p in human breast cancer promotes metastasis. Br J Cancer.
116:1350–1357. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu Y, Niu Z, Lin X and Tian Y: miR-216b
increases cisplatin sensitivity in ovarian cancer cells by
targeting PARP1. Cancer Gene Ther. 24:208–214. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zehentmayr F, Hauser-Kronberger C,
Zellinger B, Hlubek F, Schuster C, Bodenhofer U, Fastner G,
Deutschmann H, Steininger P, Reitsamer R, et al: Hsa-miR-375 is a
predictor of local control in early stage breast cancer. Clin
Epigenetics. 8(28)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
He M, Wang G, Jiang L, Qiu C, Li B, Wang J
and Fu Y: miR-486 suppresses the development of osteosarcoma by
regulating PKC-δ pathway. Int J Oncol. 50:1590–1600.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sahin Y, Altan Z, Arman K, Bozgeyik E,
Koruk OM and Arslan A: Inhibition of miR-664a interferes with the
migration of osteosarcoma cells via modulation of MEG3. Biochem
Biophys Res Commun. 490:1100–1105. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang SN, Luo S, Liu C, Piao Z, Gou W, Wang
Y, Guan W, Li Q, Zou H, Yang ZZ, et al: miR-491 inhibits
osteosarcoma lung metastasis and chemoresistance by targeting
αB-crystallin. Mol Ther. 25:2140–2149. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang C, Zhang C, Liu L, A X, Chen B, Li Y
and Du J: Macrophage-Derived mir-155-Containing exosomes suppress
fibroblast proliferation and promote fibroblast inflammation during
cardiac injury. Mol Ther. 25:192–204. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li XD, Li XM, Gu JW and Sun XC: miR-155
regulates lymphoma cell proliferation and apoptosis through
targeting SOCS3/JAK-STAT3 signaling pathway. Eur Rev Med Pharmacol
Sci. 21:5153–5159. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wei RJ, Zhang CH and Yang WZ: miR-155
affects renal carcinoma cell proliferation, invasion and apoptosis
through regulating GSK-3β/β-catenin signaling pathway. Eur Rev Med
Pharmacol Sci. 21:5034–5041. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang L, Tang B, Han H, Mao D, Chen J, Zeng
Y and Xiong M: miR-155 affects osteosarcoma MG-63 cell autophagy
induced by adriamycin through regulating PTEN-PI3K/AKT/mTOR
signaling pathway. Cancer Biother Radiopharm. 33:32–38.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen H, Liu T, Ouyang H, Lin S, Zhong H,
Zhang H and Yang Y: Upregulation of FTX promotes osteosarcoma
tumorigenesis by increasing SOX4 expression via miR-214-5p. Onco
Targets Ther. 13:7125–7136. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ruocco M, Baroncelli R, Cacciola SO, Pane
C, Monti MM, Firrao G, Vergara M, Magnano di San Lio G, Vannacci G
and Scala F: Polyketide synthases of Diaporthe helianthi and
involvement of DhPKS1 in virulence on sunflower. BMC Genomics.
19(27)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu XS, Wang F, Li HF, Hu YP, Jiang L,
Zhang F, Li ML, Wang XA, Jin YP, Zhang YJ, et al: lncRNA-PAGBC acts
as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO
Rep. 18:1837–1853. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shi HJ, Wang MW, Sun JT, Wang H, Li YF,
Chen BR, Fan Y, Wang SB, Wang ZM, Wang QM and Wang LS: A novel long
noncoding RNA FAF inhibits apoptosis via upregulating FGF9 through
PI3K/AKT signaling pathway in ischemia-hypoxia cardiomyocytes. J
Cell Physiol. 234:21973–21987. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ruan Z, Wang S, Yu W and Deng F: lncRNA
MALAT1 aggravates inflammation response through regulating PTGS2 by
targeting miR-26b in myocardial ischemia-reperfusion injury. Int J
Cardiol. 288(122)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lan T, Yuan K, Yan X, Xu L, Liao H, Hao X,
Wang J, Liu H, Xie K, Li J, et al: lncRNA SNHG10 facilitates
hepatocarcinogenesis and metastasis by modulating its homolog
SCARNA13 via a positive feedback loop. Cancer Res. 79:3220–3234.
2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sun Y, Wang J, Pan S, Yang T, Sun X, Wang
Y, Shi X, Zhao X, Guo J and Zhang X: LINC00657 played oncogenic
roles in esophageal squamous cell carcinoma by targeting miR-615-3p
and JunB. Biomed Pharmacother. 108:316–324. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wu X, Lim ZF, Li Z, Gu L, Ma W, Zhou Q, Su
H, Wang X, Yang X and Zhang Z: NORAD expression is associated with
adverse prognosis in esophageal squamous cell carcinoma. Oncol Res
Treat. 40:370–374. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang J, Li XY, Hu P and Ding YS: lncRNA
NORAD contributes to colorectal cancer progression by inhibition of
miR-202-5p. Oncol Res. 26:1411–1418. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao
C, Shen ZZ, Zhang PF, Huang XY, Ke AW, et al: The long noncoding
RNA NORAD enhances the TGF-β pathway to promote hepatocellular
carcinoma progression by targeting miR-202-5p. J Cell Physiol.
234:12051–12060. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen Y, Cao K, Li J, Wang A, Sun L, Tang
J, Xiong W, Zhou X, Chen X, Zhou J and Liu Y: Overexpression of
long non-coding RNA NORAD promotes invasion and migration in
malignant melanoma via regulating the MIR-205-EGLN2 pathway. Cancer
Med. 8:1744–1754. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wei W, Yang Y, Cai J, Cui K, Li RX, Wang
H, Shang X and Wei D: miR-30a-5p suppresses tumor metastasis of
human colorectal cancer by targeting ITGB3. Cell Physiol Biochem.
39:1165–1176. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Rice MA, Ishteiwy RA, Magani F, Udayakumar
T, Reiner T, Yates TJ, Miller P, Perez-Stable C, Rai P, Verdun R,
et al: The microRNA-23b/-27b cluster suppresses prostate cancer
metastasis via Huntingtin-interacting protein 1-related. Oncogene.
35:4752–4761. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bhattacharya S, Chalk AM, Ng AJ, Martin
TJ, Zannettino AC, Purton LE, Lu J, Baker EK and Walkley CR:
Increased miR-155-5p and reduced miR-148a-3p contribute to the
suppression of osteosarcoma cell death. Oncogene. 35:5282–5294.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen J, Wu Z and Zhang Y: lncRNA SNHG3
promotes cell growth by sponging miR-196a-5p and indicates the poor
survival in osteosarcoma. Int J Immunopathol Pharmacol.
33(2058738418820743)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang Z, Wang Z, Liu J and Yang H: Long
non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis
of osteosarcoma by targeting ROCK1. Biomed Pharmacother.
107:598–605. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Pan R, He Z, Ruan W, Li S, Chen H, Chen Z,
Liu F, Tian X and Nie Y: lncRNA FBXL19-AS1 regulates osteosarcoma
cell proliferation, migration and invasion by sponging miR-346.
Onco Targets Ther. 11:8409–8420. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yang H, Jiang Z, Wang S, Zhao Y, Song X,
Xiao Y and Yang S: Long non-coding small nucleolar RNA host genes
in digestive cancers. Cancer Med. 8:7693–7704. 2019.PubMed/NCBI View Article : Google Scholar
|
